Your browser doesn't support javascript.
loading
Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy.
Becker, Ursula; Briggs, Andrew H; Moreno, Santiago G; Ray, Joshua A; Ngo, Phuong; Samanta, Kunal.
Affiliation
  • Becker U; F. Hoffmann-La Roche Ltd., Basel, Switzerland. Electronic address: ursula.becker@roche.com.
  • Briggs AH; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Moreno SG; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Ray JA; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Ngo P; Roche Products Pty Ltd., Dee Why, New South Wales, Australia.
  • Samanta K; Genentech, a member of the Roche Group, South San Francisco, CA, USA.
Value Health ; 19(4): 374-82, 2016 Jun.
Article in En | MEDLINE | ID: mdl-27325329
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Chlorambucil / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2016 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Chlorambucil / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2016 Type: Article